The MDC Mission

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) carries out basic biomedical research with the aim of understanding the molecular basis of health and disease, and translating these findings as quickly as possible into clinical application. The research involves the diagnosis and treatment of diseases, as well as their prevention.

MDC 25 years

Research Highlights

Cutting cancer’s lifeline

A new study in the journal Nature reveals that a small signaling molecule has the ability to cut off the blood supply to tumors. This allows the immune system’s T-cells to indirectly fight cancer.


The art of folding mitochondrial membranes

Oliver Daumke's lab figures out how the inner membranes of mitochondria "get their groove" and assume the complex shapes they need to carry out crucial cellular functions


Further research highlights


“Mummy, I’m here!”

The calls of new-born mice draw the attention of their mother and enhance their chances of survival. A group of neuronal cells in the brain stem is essential for this innate process, reports a research team at the Max Delbrück Center in the journal Proceedings of the National Academy of Sciences (PNAS). Without these cells, the mice are mute. 


Biomarkers for identifying Tumor Aggressiveness

A Berlin study of patients with early-stage colon cancer shows that DNA repair mechanisms and MACC1 gene activity helps determine prognosis and predict response to chemotherapy.


Largest nationwide health study NAKO in Berlin: 3,000th participant examined in MRI scanner

We have reached the half-way mark. Ute Radeklau from Berlin is the 3,000th person to be examined in the Berlin Ultrahigh Field Facility at the Max Delbrück Center for Molecular Medicine in the context of the largest German health study NAKO. It took a good hour to take a thousand MRI images of her.


Further news on MDC Insights